Effect of tiotropium combined with salmeterol/fluticasone for the treatment of chronic obstructive pulmonary disease
Peng Li, Tao Liu, Yantong Shi
Abstract
Peng Li, Tao Liu, Yantong Shi
Abstract
Objective To study the efficacy and safety of tiotropium and salmeterol/fluticasone on chronic obstructive pulmonary disease (COPD).Methods Fifty patients with stable moderate -severe COPD were randomly divided into 3 groups:18 cases in combined group (group Ⅰ,tiotropium +salmeterol/fluticasone),15 cases in tiotropium group (group Ⅱ ),while 17 cases in salmeterol/fluticasone group ( group Ⅲ ).Three groups were given conventional oxygen,antibiotics and other symptomatic treatment,the follow - up period was 3 months.Arterial blood gas analysis,pulmonary function and 6 - minute walk distance (6MWD) were measured before and 3 months after treatment.Results PaO2,FEV1 and 6MWD were improved in all groups compared with that before treatment( P < 0.05),especially in combination group ( P < 0.05 ).Conclusions Tiotropium combined with salmeterol/fluticasone in the treatment of moderate - severe COPD with arterial blood gas analysis,pulmonary function and exercise tolerance is more effective than only tiotropium or salmeterol/fluticasone inhalation.It is safe and worthy of being extended in clinics. Key words: Chronic obstructive pulmonary disease; Tiotropium; Salmeterol/fluticasone; Blood gas analysis; Lung function
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the efficacy and safety of tiotropium and salmeterol/fluticasone on chronic obstructive pulmonary disease (COPD).Methods Fifty patients with stable moderate -severe COPD were randomly divided into 3 groups:18 cases in combined group (group Ⅰ,tiotropium +salmeterol/fluticasone),15 cases in tiotropium group (group Ⅱ ),while 17 cases in salmeterol/fluticasone group ( group Ⅲ ).Three groups were given conventional oxygen,antibiotics and other symptomatic treatment,the follow - up period was 3 months.Arterial blood gas analysis,pulmonary function and 6 - minute walk distance (6MWD) were measured before and 3 months after treatment.Results PaO2,FEV1 and 6MWD were improved in all groups compared with that before treatment( P < 0.05),especially in combination group ( P < 0.05 ).Conclusions Tiotropium combined with salmeterol/fluticasone in the treatment of moderate - severe COPD with arterial blood gas analysis,pulmonary function and exercise tolerance is more effective than only tiotropium or salmeterol/fluticasone inhalation.It is safe and worthy of being extended in clinics. Key words: Chronic obstructive pulmonary disease; Tiotropium; Salmeterol/fluticasone; Blood gas analysis; Lung function
Key concepts: Salmeterol, Medicine, Fluticasone, COPD, Pulmonary function testing, Tiotropium bromide, Inhalation, Internal medicine